Evidence map›Paper›PMID 42356136›Full record

ArticleMedicina (Kaunas, Lithuania)2026

The CALLY Index Is Associated with Overall Survival in Patients with De Novo Metastatic Gastric Adenocarcinoma.

Fahri Akgül, Süleyman Can, İvo Gökmen, Gizem Bakır Kahveci, İsmail Bayrakçı, Dicle Yurdatap Koç, Ece Demirdelen, Veli Çakıcı, Bülent Erdoğan

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Fahri AkgülDepartment of Medical Oncology, Iğdır Dr. Nevruz Erez State Hospital, Iğdır 76000, Türkiye.ORCID 0000-0003-1422-1093
Süleyman CanDepartment of Medical Oncology, Faculty of Medicine, Çanakkale Onsekiz Mart University, Çanakkale 17100, Türkiye.ORCID 0009-0000-9172-8571
İvo GökmenDepartment of Medical Oncology, Faculty of Medicine, Çanakkale Onsekiz Mart University, Çanakkale 17100, Türkiye.ORCID 0000-0002-0382-5396
Gizem Bakır KahveciDepartment of Medical Oncology, Faculty of Medicine, Trakya University, Edirne 22030, Türkiye.
İsmail BayrakçıDepartment of Medical Oncology, Faculty of Medicine, Trakya University, Edirne 22030, Türkiye.
Dicle Yurdatap KoçDepartment of Medical Oncology, Faculty of Medicine, Trakya University, Edirne 22030, Türkiye.
Ece DemirdelenDepartment of Medical Oncology, Faculty of Medicine, Trakya University, Edirne 22030, Türkiye.ORCID 0000-0002-4055-9402
Veli ÇakıcıDepartment of Medical Oncology, Faculty of Medicine, Çanakkale Onsekiz Mart University, Çanakkale 17100, Türkiye.ORCID 0000-0002-8327-7659
Bülent ErdoğanDepartment of Medical Oncology, Faculty of Medicine, Trakya University, Edirne 22030, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdenocarcinomaC-Reactive ProteinLymphocytesSerum AlbuminStomach NeoplasmsAgedBiomarkersCohort StudiesFemaleHumansKaplan-Meier EstimateLymphocyte CountMaleMiddle AgedNeoplasm MetastasisPrognosisBiomarkersC-Reactive ProteinSerum AlbuminCALLY indexgastric adenocarcinomainflammation-based biomarkermetastatic gastric canceroverall survivalprognosis

Identifiers

PMID42356136
PMCPMC13304105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.